Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;14(4):634-652.
doi: 10.1002/dta.3203. Epub 2021 Dec 10.

The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons

Robert Kronstrand  1   2 , Caitlyn Norman  3 , Svante Vikingsson  1   2   4 , Anoek Biemans  2 , Bryan Valencia Crespo  5 , Darren Edwards  6 , Daniel Fletcher  6   7 , Nicolas Gilbert  8 , Mattias Persson  1 , Robert Reid  3 , Olga Semenova  6 , Faisal Al Teneiji  3   9 , Xiongyu Wu  5 , Johan Dahlén  5 , Niamh NicDaéid  3 , Fuad Tarbah  9 , Oliver B Sutcliffe  8 , Craig McKenzie  3   10 , Henrik Gréen  1   2
Affiliations

The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons

Robert Kronstrand et al. Drug Test Anal. 2022 Apr.

Abstract

Early warning systems detect new psychoactive substances (NPS), while dedicated monitoring programs and routine drug and toxicology testing identify fluctuations in prevalence. We report the increasing prevalence of the synthetic cannabinoid receptor agonist (SCRA) ADB-BUTINACA (N-[1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carbox-amide). ADB-BUTINACA was first detected in a seizure in Sweden in 2019, and we report its detection in 13 routine Swedish forensic toxicology cases soon after. In January 2021, ADB-BUTINACA was detected in SCRA-infused papers seized in Scottish prisons and has rapidly increased in prevalence, being detected in 60.4% of the SCRA-infused papers tested between January and July 2021. In this work, ADB-BUTINACA was incubated with human hepatocytes (HHeps), and 21 metabolites were identified in vitro, 14 being detected in authentic case samples. The parent drug and metabolites B9 (mono-hydroxylation on the n-butyl tail) and B16 (mono-hydroxylation on the indazole ring) are recommended biomarkers in blood, while metabolites B4 (dihydrodiol formation on the indazole core), B9, and B16 are suitable biomarkers in urine. ADB-4en-PINACA (N-[1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[pent-4-en-1-yl]-1H-indazole-3-carboxamide) was detected in Scottish prisons in December 2020, but, unlike ADB-BUTINACA, prevalence has remained low. ADB-4en-PINACA was incubated with HHeps, and 11 metabolites were identified. Metabolites E3 (dihydrodiol formed in the tail moiety) and E7 (hydroxylation on the linked/head group) are the most abundant metabolites in vitro and are suggested as urinary biomarkers. The in vitro potencies of ADB-BUTINACA (EC50 , 11.5 nM and ADB-4en-PINACA (EC50 , 11.6 nM) are similar to that of MDMB-4en-PINACA (EC50 , 4.3 nM). A third tert-leucinamide SCRA, ADB-HEXINACA was also detected in prison samples and warrants further investigation.

Keywords: ADB-4en-PINACA; ADB-BUTINACA; metabolite identification; prisons; synthetic cannabinoid receptor agonists.

PubMed Disclaimer

References

REFERENCES

    1. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997;74(2):129-180. https://doi.org/10.1016/s0163-7258(97)82001-3
    1. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161-202.
    1. Banister SD, Connor M. The chemistry and pharmacology of synthetic cannabinoid receptor agonists as new psychoactive substances: origins. Handb Exp Pharmacol. 2018;252:165-190. https://doi.org/10.1007/164_2018_143
    1. Kevin RC, Anderson L, McGregor IS, et al. CUMYL-4CN-BINACA is an efficacious and potent pro-convulsant synthetic cannabinoid receptor agonist. Front Pharmacol. 2019;10. https://doi.org/10.3389/fphar.2019.00595
    1. Walsh KB, Andersen HK. Molecular pharmacology of synthetic cannabinoids: delineating CB1 receptor-mediated cell signaling. Int J Mol Sci. 2020;21(17):6115. https://doi.org/10.3390/ijms21176115